Pharmacists in a Complex Chronic Disease Management Clinic

Alim, Uzma; Austin-Bishop, Nyanza; Cummings, Ginny E.

doi:10.4212/cjhp.v69i6.1612

Cited by 3 publications

(6 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 The impact on chronic disease management programs, involving clinical-pharmacists, has been well demonstrated. 12 However, the 2009 ACC survey showed that many cardiologists are not familiar with the healthcare team's approach to patient care including services by clinical-pharmacists. 13 However, medication errors, drug-related problems (DRPs) and medication non-adherence are the key problems in cardiovascular disease (CVD), which accounts for more than 125,000 preventable demises annually, which is comparatively attributable to approximately one-half of patients regularly taking prescribed life-saving medications.…”

Section: Introductionmentioning

confidence: 99%

“…Clinical‐pharmacists are the ideal members of the health team in managing pharmacotherapy, modifying prescription doses, facilitating drug compliance, tracking laboratory testing, informing patients, simplifying regimens and finding alternative low‐cost treatments where necessary 11 . The impact on chronic disease management programs, involving clinical‐pharmacists, has been well demonstrated 12 . However, the 2009 ACC survey showed that many cardiologists are not familiar with the healthcare team's approach to patient care including services by clinical‐pharmacists 13 .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Frequency and nature of drug‐related problems in patients with acute coronary syndrome: role of the clinical pharmacist in coronary care practice

Gona

Shambu

Ramesh

2020

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background: Patients with acute coronary syndrome (ACS) often have associated problems either as a reason or as a corollary of the disease and drug-related problems (DRPs) are more likely to precipitate despite the presence of standard guidelines. This research is intended to evaluate the nature and extent of DRPs and examine their clinical significance in the presence of a clinical pharmacist. Methods: A clinical pharmacist-initiated cross-sectional study was carried out in the Department of Cardiology unit in a tertiary care teaching hospital for a year. The patient's medications were audited for DRPs using PCNE V 8.0.1 and drug-interactions by Micromedex. Descriptive and inferential statistics were applied whenever required by using SPSS v 25.0. Results: A total of 1120 patients screened, 432 patients were enrolled in the study by obtaining consent. The majority were in the age group 41-60 years of whom (294 (68.05 %)) were males. DRPs (367) were identified in (225 (52%)) patients of which (243 (66.13%) were due to problems in prescription, 27 (1.90%) treatment duration, followed by dispensing 43 (11.71%), drug use process 41 (11.17%) and patient-related 38 (10.35%)). The overall incidence of DRPs was 51.85%. Most risk factors were associated with DRPs (p < 0.0001). Conclusion: Drug-related problems are common in patients with acute coronary syndrome due to comorbidities and its related polypharmacy. Physician and clinical pharmacist collaboration can help in the early detection of DRPs, and alleviate the adversities emphasising optimal pharmacotherapeutic management.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Frequency and nature of drug‐related problems in patients with acute coronary syndrome: role of the clinical pharmacist in coronary care practice

Gona

Shambu

Ramesh

2020

Pharmacy Practice and Res

View full text Add to dashboard Cite

show abstract

“…Pharmacists advocate for the patient when prescriptions might no longer be indicated or might no longer provide a benefit. 4 Although pharmacists have limited resources in terms of time and funding for patient follow-up outside of clinic hours, they often work on nonclinical days to follow-up with patients with treatment problems or at the request of nurses and doctors. 4 The presence of pharmacists in the interprofessional care team should have a positive impact on the patient's recovery, including helping reduce medical costs for prescription medications and increasing the rationality of the therapy for patients with chronic diseases.…”

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Role of Pharmacists in the Interprofessional Care Team for Patients with Chronic Diseases

Rahayu¹,

Widianto²,

Defi³

et al. 2021

JMDH

View full text Add to dashboard Cite

Chronic diseases are a major health problem and cause of death worldwide. Patients with chronic diseases should be managed by an interprofessional care team consisting of general practitioners, medical specialists, nurses, and pharmacists. However, the roles of pharmacists in this interprofessional care team have not been fully explored. This study, therefore, examined their roles as members of the interprofessional care team in managing patients with chronic diseases. A search in PubMed, Google Scholar, EBSCO, Scopus, and Cochrane Library databases was conducted for research articles that discussed pharmacists, interprofessional healthcare, and chronic diseases. From initial 420 identified articles, a total of 27 articles were included in this study. The interprofessional healthcare team should have a sense of tolerance and belonging among its members, which is reflected in five dimensions: partnership, coordination, cooperation, decision-making, and therapeutic outcomes. The five dimensions are closely related because they support each other in the success of the therapy. The presence of pharmacists in an interprofessional healthcare team has been proven to help facilitate access to primary care and improve patient outcomes. Pharmacists can assist in managing chronic disease conditions by providing drug information to patients and other healthcare providers and by acting as a consultant for treatment-related issues. The pharmacist's role as part of an interprofessional care team reinforces the importance of a collaborative healthcare team in providing clinical services to patients with chronic diseases.

show abstract

A naturalistic observation study of medication counseling practices at retail chain pharmacies

Yande

Masurkar

Gopinathan

et al. 2020

Pharm Pract (Granada)

View full text Add to dashboard Cite

Objective: This study evaluated medication counseling procedures and trends at retail pharmacies in the Houston metropolitan area through a naturalistic observational study. Methods: A blinded cross-sectional observational study was conducted at retail pharmacies in the Houston metropolitan area. Data were collected by trained observers utilizing an observational log, to record various parameters that could have an impact on the duration of patient-pharmacist interaction in a naturalistic pharmacy practice setting. Additionally, indicators of counseling such as utilization of the counseling window and performance of show-and-tell were recorded. Statistical analyses included descriptive statistics, t-tests, Pearson correlations, ANOVAs, and multiple linear regressions. Results: One hundred and sixty-five interactions between patients and pharmacy staff were recorded at 45 retail pharmacies from 7 retail pharmacy chains. The counseling window was utilized in only 3 (1.81%) out of 165 observations and the show-and-tell process was observed in just 1(0.61%) interaction during this study. Mean (SD) interaction time between patient and pharmacists [159.50 (84.50)] was not statistically different (p>0.05) from the mean interaction time between patients and pharmacy technicians [139.30 (74.19)], irrespective of type of the retail chain observed. However, it was influenced by the number of patients waiting in queue. Patient wait time significantly differed by the time of the day the interaction was observed, weekends and weekdays had significantly different wait times and patient interaction times Multiple linear regression analyses indicated that, patient interaction time, pharmacy chain type, initial contact (pharmacist/technician), and time of the day, were significantly associated with patient wait time whereas patient wait time, pharmacy chain type, number of patients in queue, and number of pharmacy technician were significantly associated with interaction time. Conclusions: Our study found that the key indicators of counseling including the use of the counseling window and the show-and-tell process were absent, suggesting lack of adequate pharmacists counseling. Further studies are needed to evaluate the validity of this conclusion and the role of pharmacy services and its value towards medication use and safety.

show abstract

Pharmacists in a Complex Chronic Disease Management Clinic

Abstract: -

Cited by 3 publications

References 2 publications

Frequency and nature of drug‐related problems in patients with acute coronary syndrome: role of the clinical pharmacist in coronary care practice

Frequency and nature of drug‐related problems in patients with acute coronary syndrome: role of the clinical pharmacist in coronary care practice

Role of Pharmacists in the Interprofessional Care Team for Patients with Chronic Diseases

A naturalistic observation study of medication counseling practices at retail chain pharmacies

Contact Info

Product

Resources

About